PI-LAB-2025-179

Semaglutide, Independent Lab Report

Semaglutide 5mg · Meridian Health Direct

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.8% met the stated ≥98% claim. Content measured 98.0% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.8%

Label claimed ≥98%

Content accuracy
98%

4.9mg measured against 5mg claimed

Test recency
Older result

Published 14 months ago

Specimen PI-LAB-2025-179 Tested by Chelsea Analytical Group 8 samples tested from this company Purity & Testing score 97/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.8% Within analytical tolerance
Identity (MS) Semaglutide Confirmed Matches label
Content 5 mg 4.9 mg Within 5% of label

Methodology & chain of custody

Quantitative amino acid analysis against certified reference standard.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Chelsea Analytical Group. See our full testing methodology.

Lot / batch
D9192-25
Purchased
Analysed
Published
Laboratory
Chelsea Analytical Group
Test type
Content verification

Original laboratory report: PI-LAB-2025-179-report.pdf (document delivery arrives with the production storage backend)

More Tests, Meridian Health Direct

Semaglutide (Oral)
Purity 97.5% Verified
Orforglipron
Purity 98.1% Verified
Cagrilintide
Purity 97.0% Verified

More Tests, Semaglutide

Semaglutide Verity Research Chemicals
Purity 96.8% Verified
Semaglutide Apex Peptides
Purity 99.1% Verified
Semaglutide Cascade Research Group
Purity 96.1% Discrepancy